Skip to search formSkip to main contentSkip to account menu

JM-8

Known as: JM 8, JM8 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryCarboplatin, a new platinum analogue, was administered intravenously on a schedule of a single dose every five weeks to 23… 
2002
2002
Summary. Background: To study efficacy and safety of chemotherapy using carboplatin (JM-8) and etoposide (“JET” therapy) for the… 
2001
2001
OBJECTIVE Data concerning optimal treatment of elderly patients with ovarian cancer are scanty. The management of ovarian cancer… 
1992
1992
Qualitative and quantitative ultrastructural effects of the platinum compounds cisplatin (Platinol), carboplatin (JM8), and… 
1990
1990
We compared cis-platin (DDP) and its analogue, carboplatin (JM8, CBDCA) in their ability to inhibit spheroid growth. The… 
1990
1990
The antitumor effects and toxicities of combination chemotherapies using cisplatin (CDDP) and its analogues were compared with… 
1984
1984
Since the discovery of its antitumour activity by Rosenberg et al (1), cisplatin has achieved global recognition in the clinical…